| Identification | |
| Name: | Brimonidine D-tartrate |
| Synonyms: | Alphagan P;6-Quinoxalinamine,5-bromo-N-(4,5-dihydro- 1H-imidazol-2-yl)-,(2R,3R)-2,3-dihydroxybutanedioate (1:1);LK 14304-18;Brimonidine tartrate; |
| CAS: | 70359-46-5 |
| Molecular Formula: | C11H10BrN5.C4H6O6 |
| Molecular Weight: | 442.22 |
| InChI: | InChI=1/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1 |
| Molecular Structure: |  |
| Properties | |
| Melting Point: | 207oC |
| Density: | g/cm3 |
| Solubility: | soluble in water |
| Appearance: | Cream-light yellow powder |
| Usage: | It is an a 2 receptor agonist. It is a drug used to treat glaucoma. It acts via decreasing aqueous humor synthesis |
| Safety Data | |
 |
|
